| 1 |
32973115 | Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel. | 2021 Mar |
2 |
| 2 |
29461906 | How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy? | 2019 |
2 |
| 3 |
29869937 | Twenty-four-hour time dependency of clopidogrel effects in patients with acute coronary syndromes: The CiCAD-Study. | 2019 |
1 |
| 4 |
30745807 | Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y12 Receptor Antagonists. | 2019 |
2 |
| 5 |
30795966 | Platelet Surface CD62p and Serum Vitamin D Levels are Associated with Clopidogrel Resistance in Chinese Patients with Ischemic Stroke. | 2019 May |
1 |
| 6 |
31632514 | Monitoring of biological response to clopidogrel after treatment for non-cardioembolic ischemic stroke or transient ischemic attack. | 2019 |
1 |
| 7 |
29667460 | Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders. | 2018 Jul |
1 |
| 8 |
28630782 | Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack. | 2017 |
1 |
| 9 |
27157293 | Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease. | 2016 Apr-May |
1 |
| 10 |
25025694 | Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome. | 2015 |
1 |
| 11 |
25489921 | Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. | 2015 Jan 15 |
1 |
| 12 |
26008670 | Effect of Clopidogrel on Platelet CD Markers in Normal Individuals and in Patients with Untreated Type 2 Diabetes Mellitus. | 2015 May |
2 |
| 13 |
26156883 | Effect of P2Y12 inhibitors on inflammation and immunity. | 2015 Aug 31 |
1 |
| 14 |
26237513 | Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization. | 2015 |
1 |
| 15 |
24211510 | A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease. | 2014 Jan 28 |
1 |
| 16 |
24433232 | A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrel. | 2014 |
1 |
| 17 |
23311679 | Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel. | 2013 Oct |
2 |
| 18 |
21602258 | Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty. | 2012 Jan |
1 |
| 19 |
24293976 | No effect of clopidogrel activity or cessation on vascular function or markers of inflammation. | 2012 Dec |
1 |
| 20 |
21085001 | Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy. | 2011 Mar |
4 |
| 21 |
21497813 | The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients. | 2011 Jul |
3 |
| 22 |
19855266 | Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke. | 2010 Jan-Feb |
1 |
| 23 |
27263451 | New in vitro effects of clopidogrel on platelets in hyperlipidemic and healthy subjects. | 2010 Jun 5 |
2 |
| 24 |
18049795 | Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes. | 2009 Jan |
2 |
| 25 |
19440925 | Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. | 2009 Jun |
4 |
| 26 |
19463513 | Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting. | 2009 Jun 1 |
1 |
| 27 |
19504052 | Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study. | 2009 Nov |
1 |
| 28 |
19504141 | Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study. | 2009 Sep |
1 |
| 29 |
19618315 | Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin. | 2009 Jun |
2 |
| 30 |
17630652 | Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. | 2008 Jan |
1 |
| 31 |
18485086 | The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. | 2008 Jul |
1 |
| 32 |
17137616 | The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment. | 2007 |
1 |
| 33 |
17337040 | Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome. | 2007 |
1 |
| 34 |
17615799 | Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. | 2007 May |
1 |
| 35 |
18064330 | Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. | 2007 Dec |
2 |
| 36 |
16308186 | The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression. | 2006 Feb |
1 |
| 37 |
16386660 | Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. | 2006 Jan 3 |
1 |
| 38 |
16807649 | Enhanced platelet activation by prolactin in patients with ischemic stroke. | 2006 Jul |
1 |
| 39 |
16928609 | Effects of ad hoc clopidogrel loading versus pre-treatment on P-selectin expression after coronary stent implantation. | 2006 Aug |
3 |
| 40 |
15609386 | Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty. | 2005 Feb |
1 |
| 41 |
15968882 | P-selectin (CD62p) and P-selectin glycoprotein ligand-1 (PSGL-1) polymorphisms: minor phenotypic differences in the formation of platelet-leukocyte aggregates and response to clopidogrel. | 2005 Jun |
2 |
| 42 |
16098428 | Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. | 2005 Aug 16 |
1 |
| 43 |
16195618 | Serial changes in platelet activation in patients with unstable angina following coronary stenting: evaluation of the effects of clopidogrel loading dose in inhibiting platelet activation. | 2005 Oct |
1 |
| 44 |
16268474 | Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. | 2005 Sep |
1 |
| 45 |
16411409 | Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin. | 2005 Dec |
1 |
| 46 |
14979400 | Combination antiplatelet therapy in patients with peripheral vascular bypass grafts. | 2004 Jan |
1 |
| 47 |
15019868 | Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. | 2004 Mar 15 |
1 |
| 48 |
15155956 | Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation. | 2004 Jul |
2 |
| 49 |
15156004 | Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study. | 2004 Jun |
1 |
| 50 |
15172401 | Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. | 2004 Jun 2 |
1 |